Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Prenatal Counseling in Extreme Prematurity: Professionals' View
Completed
- Conditions
- Premature BirthExtremely Premature Infants
- Interventions
- Other: survey and interview
- First Posted Date
- 2016-05-25
- Last Posted Date
- 2016-05-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 122
- Registration Number
- NCT02782650
Prenatal Counseling in Extreme Prematurity: Parents' View
Completed
- Conditions
- Extreme PrematurityComplications
- Interventions
- Other: survey and interview
- First Posted Date
- 2016-05-25
- Last Posted Date
- 2016-05-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT02782637
Influence of BCG on TDaP-IPV Vaccination
Phase 4
- Conditions
- Whooping Cough
- Interventions
- Biological: TDaP-IPV vaccineBiological: BCG vaccine (SSI)
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT02771782
- Locations
- 🇳🇱
Radbdoudumc, Nijmegen, Netherlands
Omics Signature in the Diagnosis of Hypertension
- Conditions
- Hypertension
- Interventions
- Other: omics
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 4000
- Registration Number
- NCT02772315
- Locations
- 🇮🇹
University of Torino, Torino, Italy
🇳🇱Raddboudumc, Nijmegen, Gelderland, Netherlands
🇮🇹University of Padua, Padua, Italy
Nano MRI on 7 Tesla in Rectal and Breast Cancer
Phase 3
- Conditions
- Rectal NeoplasmsBreast Neoplasms
- Interventions
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2018-12-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02751606
- Locations
- 🇳🇱
Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 1Hypoglycemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02735031
- Locations
- 🇳🇱
Radboud university medical centre, Nijmegen, Netherlands
Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients
Phase 2
Completed
- Conditions
- VaccinesProstatic NeoplasmsImmunotherapyDendritic Cells
- Interventions
- Biological: pDC vaccinationBiological: mDC vaccinationBiological: mDC and pDC vaccination
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT02692976
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection
Phase 2
Completed
- Conditions
- MalariaPlasmodium Falciparum
- Interventions
- Biological: BCG vaccination
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02692963
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Netherlands
Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD
Not Applicable
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Other: ICS withdrawalOther: Usual care
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 620
- Registration Number
- NCT02691988
- Locations
- 🇳🇱
Radboud University Medical Centre, Department of Primary and Community Care, Nijmegen, Netherlands
Effects of Vasopressors on Immune Response
Phase 4
Completed
- Conditions
- Endotoxemia
- Interventions
- First Posted Date
- 2016-02-05
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02675868
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath